Predialysis and Postdialysis pH and Bicarbonate and Risk of All-Cause and Cardiovascular Mortality in Long-term Hemodialysis Patients
Background To date, very few studies have been carried out on the associations of pre- and postdialysis acid-base parameters with mortality in hemodialysis patients. Study Design An observational study including cross-sectional and 1-year analyses. Setting & Participants Data from the renal regi...
Gespeichert in:
Veröffentlicht in: | American journal of kidney diseases 2015-09, Vol.66 (3), p.469-478 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 478 |
---|---|
container_issue | 3 |
container_start_page | 469 |
container_title | American journal of kidney diseases |
container_volume | 66 |
creator | Yamamoto, Tadashi, PhD Shoji, Shigeichi, MD, PhD Yamakawa, Tomoyuki, MD, PhD Wada, Atsushi, MD, PhD Suzuki, Kazuyuki, MD, PhD Iseki, Kunitoshi, MD, PhD Tsubakihara, Yoshiharu, MD, PhD |
description | Background To date, very few studies have been carried out on the associations of pre- and postdialysis acid-base parameters with mortality in hemodialysis patients. Study Design An observational study including cross-sectional and 1-year analyses. Setting & Participants Data from the renal registry of the Japanese Society of Dialysis Therapy (2008-2009), including 15,132 dialysis patients 16 years or older. Predictor Predialysis pH < 7.30, 7.30 to 7.34 (reference), 7.35 to 7.39, or ≥7.40 (1,550, 4,802, 6,023, and 2,757 patients, respectively); predialysis bicarbonate level < 18.0, 18.0 to 21.9 (reference), 22.0 to 25.9, or ≥26.0 mEq/L (2,724, 7,851, 4,023, and 534 patients, respectively); postdialysis pH < 7.40, 7.40 to 7.44, 7.45 to 7.49 (reference), or ≥7.50 (2,114, 5,331, 4,975, and 2,712 patients, respectively); and postdialysis bicarbonate level < 24.0, 24.0 to 25.9, 26.0 to 27.9 (reference), or ≥28.0 mEq/L (5,087, 4,330, 3,451, and 2,264 patients, respectively). Outcomes All-cause and cardiovascular (CV) mortality during the 1-year follow-up. Measurements HRs were estimated using unadjusted models and models adjusted for age, sex, dialysis vintage, history of CV disease, diabetes, weight gain ratio, body mass index, calcium-phosphorus product, serum albumin level, serum total cholesterol level, blood hemoglobin level, single-pool Kt/V, and normalized protein catabolic rate. Results Of 15,132 patients, during follow-up, 1,042 died of all causes, including 408 CV deaths. In the adjusted analysis for all-cause mortality, HRs compared to the reference group were significantly higher in patients with predialysis pH ≥ 7.40 (HR, 1.36; 95% CI, 1.13-1.65) and postdialysis pH < 7.40 (HR, 1.22; 95% CI, 1.00-1.49). Predialysis pH ≥ 7.40 was also associated with higher risk of CV mortality (HR, 1.34; 95% CI, 1.01-1.79). No association of pre- or postdialysis bicarbonate level with all-cause and CV mortality was observed. Limitations Single measurements of acid-base parameters, short duration of follow-up, small number of CV deaths. Conclusions Predialysis pH ≥ 7.40 was associated with significantly elevated risk of all-cause and CV mortality. However, pre- and postdialysis bicarbonate levels were not associated with all-cause and CV mortality. Predialysis pH may be the most appropriate reference for accurate correction of metabolic acidosis in dialysis patients. |
doi_str_mv | 10.1053/j.ajkd.2015.04.014 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1706577547</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0272638615007052</els_id><sourcerecordid>1706577547</sourcerecordid><originalsourceid>FETCH-LOGICAL-c547t-ab6ac970b48b3db79b751ce5ef106d1498933b79007cebcc4b2f94bbc91163943</originalsourceid><addsrcrecordid>eNp9ksFu1DAURS0EokPhB1igLNkk2HFiJxJCakfAIA3qqMDasp0X5IwTD7ZTaT6g_43TKbPogpXlq3uv5fMeQm8JLgiu6YehkMO-K0pM6gJXBSbVM7QidUlz1tDmOVrhkpc5ow27QK9CGDDGLWXsJbooWcqUnK3Q_c5DZ6Q9BhMyOXXZzoV4Fg6bB-3aaOmVm2SEh_utCfvM9dmVtflazuGkrqXvjLuTQc9W-uy781FaE4-ZmbKtm37nEfyYbWB05_6djAamGF6jF720Ad48npfo15fPP9ebfHvz9dv6apvruuIxl4pJ3XKsqkbRTvFW8ZpoqKEnmHWkapuW0iRjzDUorStV9m2llG4JYbSt6CV6f-o9ePdnhhDFaIIGa-UEbg6CcMxqztNjyVqerNq7EDz04uDNKP1RECwW_GIQC36x4Be4Egl_Cr177J_VCN058o93Mnw8GSD98s6AF0EnAjrNwIOOonPm__2fnsS1NVOajt3DEcLgZj8lfoKIUAosfiwLsMyf1AkJTpvxF43ArKo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1706577547</pqid></control><display><type>article</type><title>Predialysis and Postdialysis pH and Bicarbonate and Risk of All-Cause and Cardiovascular Mortality in Long-term Hemodialysis Patients</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Yamamoto, Tadashi, PhD ; Shoji, Shigeichi, MD, PhD ; Yamakawa, Tomoyuki, MD, PhD ; Wada, Atsushi, MD, PhD ; Suzuki, Kazuyuki, MD, PhD ; Iseki, Kunitoshi, MD, PhD ; Tsubakihara, Yoshiharu, MD, PhD</creator><creatorcontrib>Yamamoto, Tadashi, PhD ; Shoji, Shigeichi, MD, PhD ; Yamakawa, Tomoyuki, MD, PhD ; Wada, Atsushi, MD, PhD ; Suzuki, Kazuyuki, MD, PhD ; Iseki, Kunitoshi, MD, PhD ; Tsubakihara, Yoshiharu, MD, PhD</creatorcontrib><description><![CDATA[Background To date, very few studies have been carried out on the associations of pre- and postdialysis acid-base parameters with mortality in hemodialysis patients. Study Design An observational study including cross-sectional and 1-year analyses. Setting & Participants Data from the renal registry of the Japanese Society of Dialysis Therapy (2008-2009), including 15,132 dialysis patients 16 years or older. Predictor Predialysis pH < 7.30, 7.30 to 7.34 (reference), 7.35 to 7.39, or ≥7.40 (1,550, 4,802, 6,023, and 2,757 patients, respectively); predialysis bicarbonate level < 18.0, 18.0 to 21.9 (reference), 22.0 to 25.9, or ≥26.0 mEq/L (2,724, 7,851, 4,023, and 534 patients, respectively); postdialysis pH < 7.40, 7.40 to 7.44, 7.45 to 7.49 (reference), or ≥7.50 (2,114, 5,331, 4,975, and 2,712 patients, respectively); and postdialysis bicarbonate level < 24.0, 24.0 to 25.9, 26.0 to 27.9 (reference), or ≥28.0 mEq/L (5,087, 4,330, 3,451, and 2,264 patients, respectively). Outcomes All-cause and cardiovascular (CV) mortality during the 1-year follow-up. Measurements HRs were estimated using unadjusted models and models adjusted for age, sex, dialysis vintage, history of CV disease, diabetes, weight gain ratio, body mass index, calcium-phosphorus product, serum albumin level, serum total cholesterol level, blood hemoglobin level, single-pool Kt/V, and normalized protein catabolic rate. Results Of 15,132 patients, during follow-up, 1,042 died of all causes, including 408 CV deaths. In the adjusted analysis for all-cause mortality, HRs compared to the reference group were significantly higher in patients with predialysis pH ≥ 7.40 (HR, 1.36; 95% CI, 1.13-1.65) and postdialysis pH < 7.40 (HR, 1.22; 95% CI, 1.00-1.49). Predialysis pH ≥ 7.40 was also associated with higher risk of CV mortality (HR, 1.34; 95% CI, 1.01-1.79). No association of pre- or postdialysis bicarbonate level with all-cause and CV mortality was observed. Limitations Single measurements of acid-base parameters, short duration of follow-up, small number of CV deaths. Conclusions Predialysis pH ≥ 7.40 was associated with significantly elevated risk of all-cause and CV mortality. However, pre- and postdialysis bicarbonate levels were not associated with all-cause and CV mortality. Predialysis pH may be the most appropriate reference for accurate correction of metabolic acidosis in dialysis patients.]]></description><identifier>ISSN: 0272-6386</identifier><identifier>EISSN: 1523-6838</identifier><identifier>DOI: 10.1053/j.ajkd.2015.04.014</identifier><identifier>PMID: 26015276</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>acid-base status ; Aged ; all-cause mortality ; Cardiovascular Diseases - mortality ; cardiovascular mortality ; Cause of Death ; dialysate bicarbonate ; end-stage renal disease (ESRD) ; Female ; hemodialysis ; Humans ; Hydrogen-Ion Concentration ; Japanese Renal Data Registry (JRDR) ; Kidney Failure, Chronic - mortality ; Kidney Failure, Chronic - therapy ; Male ; metabolic acidosis ; Middle Aged ; Multivariate Analysis ; Nephrology ; postdialysis pH ; Predialysis pH ; Renal Dialysis - mortality ; renal replacement therapy ; Risk Assessment ; serum bicarbonate ; Sodium Bicarbonate - blood</subject><ispartof>American journal of kidney diseases, 2015-09, Vol.66 (3), p.469-478</ispartof><rights>National Kidney Foundation, Inc.</rights><rights>2015 National Kidney Foundation, Inc.</rights><rights>Copyright © 2015 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c547t-ab6ac970b48b3db79b751ce5ef106d1498933b79007cebcc4b2f94bbc91163943</citedby><cites>FETCH-LOGICAL-c547t-ab6ac970b48b3db79b751ce5ef106d1498933b79007cebcc4b2f94bbc91163943</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0272638615007052$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26015276$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamamoto, Tadashi, PhD</creatorcontrib><creatorcontrib>Shoji, Shigeichi, MD, PhD</creatorcontrib><creatorcontrib>Yamakawa, Tomoyuki, MD, PhD</creatorcontrib><creatorcontrib>Wada, Atsushi, MD, PhD</creatorcontrib><creatorcontrib>Suzuki, Kazuyuki, MD, PhD</creatorcontrib><creatorcontrib>Iseki, Kunitoshi, MD, PhD</creatorcontrib><creatorcontrib>Tsubakihara, Yoshiharu, MD, PhD</creatorcontrib><title>Predialysis and Postdialysis pH and Bicarbonate and Risk of All-Cause and Cardiovascular Mortality in Long-term Hemodialysis Patients</title><title>American journal of kidney diseases</title><addtitle>Am J Kidney Dis</addtitle><description><![CDATA[Background To date, very few studies have been carried out on the associations of pre- and postdialysis acid-base parameters with mortality in hemodialysis patients. Study Design An observational study including cross-sectional and 1-year analyses. Setting & Participants Data from the renal registry of the Japanese Society of Dialysis Therapy (2008-2009), including 15,132 dialysis patients 16 years or older. Predictor Predialysis pH < 7.30, 7.30 to 7.34 (reference), 7.35 to 7.39, or ≥7.40 (1,550, 4,802, 6,023, and 2,757 patients, respectively); predialysis bicarbonate level < 18.0, 18.0 to 21.9 (reference), 22.0 to 25.9, or ≥26.0 mEq/L (2,724, 7,851, 4,023, and 534 patients, respectively); postdialysis pH < 7.40, 7.40 to 7.44, 7.45 to 7.49 (reference), or ≥7.50 (2,114, 5,331, 4,975, and 2,712 patients, respectively); and postdialysis bicarbonate level < 24.0, 24.0 to 25.9, 26.0 to 27.9 (reference), or ≥28.0 mEq/L (5,087, 4,330, 3,451, and 2,264 patients, respectively). Outcomes All-cause and cardiovascular (CV) mortality during the 1-year follow-up. Measurements HRs were estimated using unadjusted models and models adjusted for age, sex, dialysis vintage, history of CV disease, diabetes, weight gain ratio, body mass index, calcium-phosphorus product, serum albumin level, serum total cholesterol level, blood hemoglobin level, single-pool Kt/V, and normalized protein catabolic rate. Results Of 15,132 patients, during follow-up, 1,042 died of all causes, including 408 CV deaths. In the adjusted analysis for all-cause mortality, HRs compared to the reference group were significantly higher in patients with predialysis pH ≥ 7.40 (HR, 1.36; 95% CI, 1.13-1.65) and postdialysis pH < 7.40 (HR, 1.22; 95% CI, 1.00-1.49). Predialysis pH ≥ 7.40 was also associated with higher risk of CV mortality (HR, 1.34; 95% CI, 1.01-1.79). No association of pre- or postdialysis bicarbonate level with all-cause and CV mortality was observed. Limitations Single measurements of acid-base parameters, short duration of follow-up, small number of CV deaths. Conclusions Predialysis pH ≥ 7.40 was associated with significantly elevated risk of all-cause and CV mortality. However, pre- and postdialysis bicarbonate levels were not associated with all-cause and CV mortality. Predialysis pH may be the most appropriate reference for accurate correction of metabolic acidosis in dialysis patients.]]></description><subject>acid-base status</subject><subject>Aged</subject><subject>all-cause mortality</subject><subject>Cardiovascular Diseases - mortality</subject><subject>cardiovascular mortality</subject><subject>Cause of Death</subject><subject>dialysate bicarbonate</subject><subject>end-stage renal disease (ESRD)</subject><subject>Female</subject><subject>hemodialysis</subject><subject>Humans</subject><subject>Hydrogen-Ion Concentration</subject><subject>Japanese Renal Data Registry (JRDR)</subject><subject>Kidney Failure, Chronic - mortality</subject><subject>Kidney Failure, Chronic - therapy</subject><subject>Male</subject><subject>metabolic acidosis</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Nephrology</subject><subject>postdialysis pH</subject><subject>Predialysis pH</subject><subject>Renal Dialysis - mortality</subject><subject>renal replacement therapy</subject><subject>Risk Assessment</subject><subject>serum bicarbonate</subject><subject>Sodium Bicarbonate - blood</subject><issn>0272-6386</issn><issn>1523-6838</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9ksFu1DAURS0EokPhB1igLNkk2HFiJxJCakfAIA3qqMDasp0X5IwTD7ZTaT6g_43TKbPogpXlq3uv5fMeQm8JLgiu6YehkMO-K0pM6gJXBSbVM7QidUlz1tDmOVrhkpc5ow27QK9CGDDGLWXsJbooWcqUnK3Q_c5DZ6Q9BhMyOXXZzoV4Fg6bB-3aaOmVm2SEh_utCfvM9dmVtflazuGkrqXvjLuTQc9W-uy781FaE4-ZmbKtm37nEfyYbWB05_6djAamGF6jF720Ad48npfo15fPP9ebfHvz9dv6apvruuIxl4pJ3XKsqkbRTvFW8ZpoqKEnmHWkapuW0iRjzDUorStV9m2llG4JYbSt6CV6f-o9ePdnhhDFaIIGa-UEbg6CcMxqztNjyVqerNq7EDz04uDNKP1RECwW_GIQC36x4Be4Egl_Cr177J_VCN058o93Mnw8GSD98s6AF0EnAjrNwIOOonPm__2fnsS1NVOajt3DEcLgZj8lfoKIUAosfiwLsMyf1AkJTpvxF43ArKo</recordid><startdate>20150901</startdate><enddate>20150901</enddate><creator>Yamamoto, Tadashi, PhD</creator><creator>Shoji, Shigeichi, MD, PhD</creator><creator>Yamakawa, Tomoyuki, MD, PhD</creator><creator>Wada, Atsushi, MD, PhD</creator><creator>Suzuki, Kazuyuki, MD, PhD</creator><creator>Iseki, Kunitoshi, MD, PhD</creator><creator>Tsubakihara, Yoshiharu, MD, PhD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150901</creationdate><title>Predialysis and Postdialysis pH and Bicarbonate and Risk of All-Cause and Cardiovascular Mortality in Long-term Hemodialysis Patients</title><author>Yamamoto, Tadashi, PhD ; Shoji, Shigeichi, MD, PhD ; Yamakawa, Tomoyuki, MD, PhD ; Wada, Atsushi, MD, PhD ; Suzuki, Kazuyuki, MD, PhD ; Iseki, Kunitoshi, MD, PhD ; Tsubakihara, Yoshiharu, MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c547t-ab6ac970b48b3db79b751ce5ef106d1498933b79007cebcc4b2f94bbc91163943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>acid-base status</topic><topic>Aged</topic><topic>all-cause mortality</topic><topic>Cardiovascular Diseases - mortality</topic><topic>cardiovascular mortality</topic><topic>Cause of Death</topic><topic>dialysate bicarbonate</topic><topic>end-stage renal disease (ESRD)</topic><topic>Female</topic><topic>hemodialysis</topic><topic>Humans</topic><topic>Hydrogen-Ion Concentration</topic><topic>Japanese Renal Data Registry (JRDR)</topic><topic>Kidney Failure, Chronic - mortality</topic><topic>Kidney Failure, Chronic - therapy</topic><topic>Male</topic><topic>metabolic acidosis</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Nephrology</topic><topic>postdialysis pH</topic><topic>Predialysis pH</topic><topic>Renal Dialysis - mortality</topic><topic>renal replacement therapy</topic><topic>Risk Assessment</topic><topic>serum bicarbonate</topic><topic>Sodium Bicarbonate - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamamoto, Tadashi, PhD</creatorcontrib><creatorcontrib>Shoji, Shigeichi, MD, PhD</creatorcontrib><creatorcontrib>Yamakawa, Tomoyuki, MD, PhD</creatorcontrib><creatorcontrib>Wada, Atsushi, MD, PhD</creatorcontrib><creatorcontrib>Suzuki, Kazuyuki, MD, PhD</creatorcontrib><creatorcontrib>Iseki, Kunitoshi, MD, PhD</creatorcontrib><creatorcontrib>Tsubakihara, Yoshiharu, MD, PhD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of kidney diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamamoto, Tadashi, PhD</au><au>Shoji, Shigeichi, MD, PhD</au><au>Yamakawa, Tomoyuki, MD, PhD</au><au>Wada, Atsushi, MD, PhD</au><au>Suzuki, Kazuyuki, MD, PhD</au><au>Iseki, Kunitoshi, MD, PhD</au><au>Tsubakihara, Yoshiharu, MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Predialysis and Postdialysis pH and Bicarbonate and Risk of All-Cause and Cardiovascular Mortality in Long-term Hemodialysis Patients</atitle><jtitle>American journal of kidney diseases</jtitle><addtitle>Am J Kidney Dis</addtitle><date>2015-09-01</date><risdate>2015</risdate><volume>66</volume><issue>3</issue><spage>469</spage><epage>478</epage><pages>469-478</pages><issn>0272-6386</issn><eissn>1523-6838</eissn><abstract><![CDATA[Background To date, very few studies have been carried out on the associations of pre- and postdialysis acid-base parameters with mortality in hemodialysis patients. Study Design An observational study including cross-sectional and 1-year analyses. Setting & Participants Data from the renal registry of the Japanese Society of Dialysis Therapy (2008-2009), including 15,132 dialysis patients 16 years or older. Predictor Predialysis pH < 7.30, 7.30 to 7.34 (reference), 7.35 to 7.39, or ≥7.40 (1,550, 4,802, 6,023, and 2,757 patients, respectively); predialysis bicarbonate level < 18.0, 18.0 to 21.9 (reference), 22.0 to 25.9, or ≥26.0 mEq/L (2,724, 7,851, 4,023, and 534 patients, respectively); postdialysis pH < 7.40, 7.40 to 7.44, 7.45 to 7.49 (reference), or ≥7.50 (2,114, 5,331, 4,975, and 2,712 patients, respectively); and postdialysis bicarbonate level < 24.0, 24.0 to 25.9, 26.0 to 27.9 (reference), or ≥28.0 mEq/L (5,087, 4,330, 3,451, and 2,264 patients, respectively). Outcomes All-cause and cardiovascular (CV) mortality during the 1-year follow-up. Measurements HRs were estimated using unadjusted models and models adjusted for age, sex, dialysis vintage, history of CV disease, diabetes, weight gain ratio, body mass index, calcium-phosphorus product, serum albumin level, serum total cholesterol level, blood hemoglobin level, single-pool Kt/V, and normalized protein catabolic rate. Results Of 15,132 patients, during follow-up, 1,042 died of all causes, including 408 CV deaths. In the adjusted analysis for all-cause mortality, HRs compared to the reference group were significantly higher in patients with predialysis pH ≥ 7.40 (HR, 1.36; 95% CI, 1.13-1.65) and postdialysis pH < 7.40 (HR, 1.22; 95% CI, 1.00-1.49). Predialysis pH ≥ 7.40 was also associated with higher risk of CV mortality (HR, 1.34; 95% CI, 1.01-1.79). No association of pre- or postdialysis bicarbonate level with all-cause and CV mortality was observed. Limitations Single measurements of acid-base parameters, short duration of follow-up, small number of CV deaths. Conclusions Predialysis pH ≥ 7.40 was associated with significantly elevated risk of all-cause and CV mortality. However, pre- and postdialysis bicarbonate levels were not associated with all-cause and CV mortality. Predialysis pH may be the most appropriate reference for accurate correction of metabolic acidosis in dialysis patients.]]></abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26015276</pmid><doi>10.1053/j.ajkd.2015.04.014</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0272-6386 |
ispartof | American journal of kidney diseases, 2015-09, Vol.66 (3), p.469-478 |
issn | 0272-6386 1523-6838 |
language | eng |
recordid | cdi_proquest_miscellaneous_1706577547 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | acid-base status Aged all-cause mortality Cardiovascular Diseases - mortality cardiovascular mortality Cause of Death dialysate bicarbonate end-stage renal disease (ESRD) Female hemodialysis Humans Hydrogen-Ion Concentration Japanese Renal Data Registry (JRDR) Kidney Failure, Chronic - mortality Kidney Failure, Chronic - therapy Male metabolic acidosis Middle Aged Multivariate Analysis Nephrology postdialysis pH Predialysis pH Renal Dialysis - mortality renal replacement therapy Risk Assessment serum bicarbonate Sodium Bicarbonate - blood |
title | Predialysis and Postdialysis pH and Bicarbonate and Risk of All-Cause and Cardiovascular Mortality in Long-term Hemodialysis Patients |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T07%3A41%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Predialysis%20and%20Postdialysis%20pH%20and%20Bicarbonate%20and%20Risk%20of%20All-Cause%20and%20Cardiovascular%20Mortality%20in%20Long-term%20Hemodialysis%20Patients&rft.jtitle=American%20journal%20of%20kidney%20diseases&rft.au=Yamamoto,%20Tadashi,%20PhD&rft.date=2015-09-01&rft.volume=66&rft.issue=3&rft.spage=469&rft.epage=478&rft.pages=469-478&rft.issn=0272-6386&rft.eissn=1523-6838&rft_id=info:doi/10.1053/j.ajkd.2015.04.014&rft_dat=%3Cproquest_cross%3E1706577547%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1706577547&rft_id=info:pmid/26015276&rft_els_id=S0272638615007052&rfr_iscdi=true |